| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| 1 | AN ACT concerning health.
| ||||||||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||
| 3 | represented in the General Assembly:
| ||||||||||||||||||||||||
| 4 | Section 1. Short title. This Act may be cited as the | ||||||||||||||||||||||||
| 5 | Administration of Antibiotics to Food-Producing Animals Act. | ||||||||||||||||||||||||
| 6 | Section 5. Findings; purpose. | ||||||||||||||||||||||||
| 7 | (a) The General Assembly finds and declares that: | ||||||||||||||||||||||||
| 8 | (1) the World Health Organization has stated that | ||||||||||||||||||||||||
| 9 | "without urgent, coordinated action by many stakeholders, | ||||||||||||||||||||||||
| 10 | the world is headed for a post-antibiotic era, in which | ||||||||||||||||||||||||
| 11 | common infections and minor injuries which have been | ||||||||||||||||||||||||
| 12 | treatable for decades can once again kill"; | ||||||||||||||||||||||||
| 13 | (2) the United States Food and Drug Administration and | ||||||||||||||||||||||||
| 14 | the Centers for Disease Control and Prevention have stated | ||||||||||||||||||||||||
| 15 | that there is a definitive link between the use of | ||||||||||||||||||||||||
| 16 | antibiotics on industrial farms and the crisis of | ||||||||||||||||||||||||
| 17 | antibiotic resistance in humans; | ||||||||||||||||||||||||
| 18 | (3) the issue of antibiotics overuse, whether on humans | ||||||||||||||||||||||||
| 19 | or animals, is a significant and urgent human health | ||||||||||||||||||||||||
| 20 | matter; | ||||||||||||||||||||||||
| 21 | (4) the World Health Organization recommends "complete | ||||||||||||||||||||||||
| 22 | restriction of use of all classes of medically important | ||||||||||||||||||||||||
| 23 | antimicrobials in food-producing animals for prevention of | ||||||||||||||||||||||||
| |||||||
| |||||||
| 1 | infectious diseases that have not yet been clinically | ||||||
| 2 | diagnosed"; | ||||||
| 3 | (5) nearly 70% of medically important antibiotics sold | ||||||
| 4 | in the United States are given to food-producing animals, | ||||||
| 5 | often to compensate for the effects of unsanitary and | ||||||
| 6 | overcrowded living conditions;
| ||||||
| 7 | (6) many of the antibiotics provided to food-producing | ||||||
| 8 | animals are identical to, or from the same family as, drugs | ||||||
| 9 | used in human medicine to cure serious diseases; therefore, | ||||||
| 10 | bacterial resistance to these drugs poses a threat to human | ||||||
| 11 | health because these drugs may not work to treat human | ||||||
| 12 | disease when needed; and | ||||||
| 13 | (7) passing this Act is necessary to protect the health | ||||||
| 14 | and safety of Illinois consumers from antibiotic resistant | ||||||
| 15 | bacteria spreading through the food supply.
| ||||||
| 16 | (b) The purpose of this Act is to protect public health by | ||||||
| 17 | preserving the effectiveness of antibiotics now and for future | ||||||
| 18 | generations by eliminating the use of those important medicines | ||||||
| 19 | in food-producing animals for disease prevention, in order to | ||||||
| 20 | reduce the rise and spread of antibiotic resistant bacteria.
| ||||||
| 21 | Section 10. Definitions. As used in this Act: | ||||||
| 22 | "Control the spread of a disease or infection" means the | ||||||
| 23 | use of a medically important antibiotic to stop the | ||||||
| 24 | transmission of a documented disease or infection present in: | ||||||
| 25 | (1) a group of animals in contact with each other; or | ||||||
| |||||||
| |||||||
| 1 | (2) a barn or equivalent animal housing unit.
| ||||||
| 2 | "Department" means the Department of Public Health. | ||||||
| 3 | "Disease prevention" means the administration of a | ||||||
| 4 | medically important antibiotic to an animal or multiple animals | ||||||
| 5 | in the absence of contact with animals with a clinically | ||||||
| 6 | diagnosed disease for the purpose of avoiding illness. | ||||||
| 7 | "Food-producing animal" means: | ||||||
| 8 | (1) cattle, swine, or poultry, regardless of whether | ||||||
| 9 | the specific animal is raised for the purpose of producing | ||||||
| 10 | food for human consumption; or | ||||||
| 11 | (2) any type of animal that the Department identifies | ||||||
| 12 | by rule as livestock typically used to produce food for | ||||||
| 13 | human consumption.
| ||||||
| 14 | "Medically important antibiotic" means a drug that is | ||||||
| 15 | composed in whole or in part of a drug from an antimicrobial | ||||||
| 16 | class that is categorized as critically important, highly | ||||||
| 17 | important, or important in the World Health Organization list | ||||||
| 18 | of Critically Important Antimicrobials for Human Medicine (5th | ||||||
| 19 | Revision, 2017), or a subsequent revision or successor document | ||||||
| 20 | issued by the World Health Organization. | ||||||
| 21 | "Producer" means a person or entity that establishes | ||||||
| 22 | management and production standards for the maintenance, care, | ||||||
| 23 | and raising of food-producing animals and that: | ||||||
| 24 | (1) operates a business raising food-producing animals | ||||||
| 25 | that are used to produce any product group sold by a | ||||||
| 26 | grocer; or | ||||||
| |||||||
| |||||||
| 1 | (2) purchases or otherwise obtains live food-producing | ||||||
| 2 | animals that it slaughters, or sells for slaughter, for | ||||||
| 3 | production of any product group sold by a grocer.
| ||||||
| 4 | "Treat a disease" means administering a medically | ||||||
| 5 | important antibiotic to infected individual animals or | ||||||
| 6 | populations of animals to resolve clinical signs of infection | ||||||
| 7 | or illness.
| ||||||
| 8 | Section 15. Administration of antibiotics to | ||||||
| 9 | food-producing animals. | ||||||
| 10 | (a) This Section applies to the provision of medically | ||||||
| 11 | important antibiotics to food-producing animals on or after | ||||||
| 12 | January 1, 2021. | ||||||
| 13 | (b) A medically important antibiotic may be administered to | ||||||
| 14 | a food-producing animal only if prescribed by a veterinarian | ||||||
| 15 | licensed under the Veterinary Medicine and Surgery Practice Act | ||||||
| 16 | of 2004 who has visited the farm operation within the previous | ||||||
| 17 | 6 months and only if deemed necessary: | ||||||
| 18 | (1) to treat a disease; | ||||||
| 19 | (2) to control the spread of a disease or infection; or | ||||||
| 20 | (3) in relation to a surgical or other medical | ||||||
| 21 | procedure that exposes normally sterile body sites to | ||||||
| 22 | infection. | ||||||
| 23 | (c) A producer may provide a medically important antibiotic | ||||||
| 24 | to a food-producing animal only for the period necessary to | ||||||
| 25 | accomplish a purpose described in subsection (b). In that case, | ||||||
| |||||||
| |||||||
| 1 | antibiotics should be used on the smallest number of animals | ||||||
| 2 | and for the shortest time possible. In addition to any | ||||||
| 3 | information described in Section 20, the producer shall keep a | ||||||
| 4 | record of the specific beginning and ending dates for the | ||||||
| 5 | provision of an antibiotic. | ||||||
| 6 | (d) A medically important antibiotic may not be | ||||||
| 7 | administered to food-producing animals solely for the purpose | ||||||
| 8 | of:
| ||||||
| 9 | (1) promoting weight gain; | ||||||
| 10 | (2) improving feed efficiency; or | ||||||
| 11 | (3) disease prevention. | ||||||
| 12 | Section 20. Annual report. | ||||||
| 13 | (a) A producer that operates a large concentrated animal | ||||||
| 14 | feeding operation, as defined by the United States | ||||||
| 15 | Environmental Protection Agency, must file an annual report | ||||||
| 16 | under this Section in a form and manner required by the | ||||||
| 17 | Department by rule. If the producer and a contracting entity | ||||||
| 18 | enter into an agreement for the contracting entity to assume | ||||||
| 19 | the annual report filing duty, the contracting entity shall | ||||||
| 20 | include in the annual report the name and address of the | ||||||
| 21 | producer on whose behalf the contracting entity is submitting | ||||||
| 22 | the annual report. If any medically important antibiotics were | ||||||
| 23 | provided to food-producing animals during the reporting | ||||||
| 24 | period, then the annual report must contain the following | ||||||
| 25 | information: | ||||||
| |||||||
| |||||||
| 1 | (1) the location of the facility where the medically | ||||||
| 2 | important antibiotic was used; | ||||||
| 3 | (2) the medically important antibiotic and class of | ||||||
| 4 | antimicrobial used; | ||||||
| 5 | (3) the duration of use, including the number of | ||||||
| 6 | treatment days; | ||||||
| 7 | (4) the species and production class of animals | ||||||
| 8 | receiving the medically important antibiotic; | ||||||
| 9 | (5) the number of animals receiving the medically | ||||||
| 10 | important antibiotic; | ||||||
| 11 | (6) the total number of animals raised at the facility, | ||||||
| 12 | this data is key to understanding variations in use and | ||||||
| 13 | benchmarking performance; | ||||||
| 14 | (7) the indication and purpose for which the | ||||||
| 15 | veterinarian prescribed the medically important | ||||||
| 16 | antibiotic; | ||||||
| 17 | (8) the dosage of the medically important antibiotic; | ||||||
| 18 | (9) the quantity of each medically important | ||||||
| 19 | antibiotic prescribed to each species of food-producing | ||||||
| 20 | animal; | ||||||
| 21 | (10) the method for providing each medically important | ||||||
| 22 | antibiotic to a food-producing animal; and
| ||||||
| 23 | (11) any other information required to be kept pursuant | ||||||
| 24 | to U.S. Food and Drug Administration regulations 21 CFR | ||||||
| 25 | 558.6(b)(3) and 21 CFR 558.6(b)(4).
| ||||||
| 26 | (b) Information provided under paragraph (7) of subsection | ||||||
| |||||||
| |||||||
| 1 | (a) must include whether a medically-important antibiotic was | ||||||
| 2 | provided to a food-producing animal for the purpose of: | ||||||
| 3 | (1) surgery or a medical procedure; | ||||||
| 4 | (2) disease control; or | ||||||
| 5 | (3) disease treatment. | ||||||
| 6 | (c) Information reported under this Section shall be made | ||||||
| 7 | publicly available by the Department annually in a searchable | ||||||
| 8 | database of aggregated data on its website, except that the | ||||||
| 9 | Department shall withhold the identities of individual | ||||||
| 10 | producers. | ||||||
| 11 | (d) Except as otherwise provided in subsection (c), | ||||||
| 12 | information reported under this Section is a public record and | ||||||
| 13 | is not subject to exemption from disclosure. The Department may | ||||||
| 14 | not redact, withhold, or delay the release of information, | ||||||
| 15 | except the identities of individual producers pursuant to | ||||||
| 16 | subsection (c), reported under this Section. | ||||||
| 17 | (e) The Department of Public Health shall consult with the | ||||||
| 18 | Department of Agriculture as necessary to fulfill the | ||||||
| 19 | requirements of this Section. | ||||||
| 20 | Section 25. Implementation. The Department may take the | ||||||
| 21 | actions necessary to prepare to implement the provisions of | ||||||
| 22 | this Act in advance of the effective date of the other | ||||||
| 23 | provisions of this Act. | ||||||
| 24 | Section 30. Violations. The Attorney General has exclusive | ||||||
| |||||||
| |||||||
| 1 | authority to enforce the provisions of this Act. Each violation | ||||||
| 2 | of this Act is punishable by a civil penalty not to exceed | ||||||
| 3 | $1,000. The Attorney General may also seek injunctive relief to | ||||||
| 4 | prevent further violations of this Act.
| ||||||